1
|
Hoffman JI and Kaplan S: The incidence of
congenital heart disease. J Am Coll Cardiol. 39:1890–1900.
2002.PubMed/NCBI View Article : Google Scholar
|
2
|
Yuan S, Zaidi S and Brueckner M:
Congenital heart disease: Emerging themes linking genetics and
development. Curr Opin Genet Dev. 23:352–359. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
Vecoli C, Pulignani S, Foffa I and
Andreassi MG: Congenital heart disease: The crossroads of genetics,
epigenetics and environment. Curr Genomics. 15:390–399.
2014.PubMed/NCBI View Article : Google Scholar
|
4
|
Jarrell DK, Lennon ML and Jacot JG:
Epigenetics and mechanobiology in heart development and congenital
heart disease. Diseases. 7(52)2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Greenberg MVC and Bourc'his D: The diverse
roles of DNA methylation in mammalian development and disease. Nat
Rev Mol Cell Biol. 20:590–607. 2019.PubMed/NCBI View Article : Google Scholar
|
6
|
Bahado-Singh RO, Zaffra R, Albayarak S,
Chelliah A, Bolinjkar R, Turkoglu O and Radhakrishna U: Epigenetic
markers for newborn congenital heart defect (CHD). J Matern Fetal
Neonatal Med. 29:1881–1887. 2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Radhakrishna U, Albayrak S, Zafra R, Baraa
A, Vishweswaraiah S, Veerappa AM, Mahishi D, Saiyed N, Mishra NK,
Guda C, et al: Placental epigenetics for evaluation of fetal
congenital heart defects: Ventricular septal defect (VSD). PLoS
One. 14(e0200229)2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Bahado-Singh R, Vishweswaraiah S, Mishra
NK, Guda C and Radhakrishna U: Placental DNA methylation changes
for the detection of tetralogy of Fallot. Ultrasound Obstet
Gynecol. 55:768–775. 2020.PubMed/NCBI View Article : Google Scholar
|
9
|
Sheng W, Wang H, Ma X, Qian Y, Zhang P, Wu
Y, Zheng F, Chen L, Huang G and Ma D: LINE-1 methylation status and
its association with tetralogy of fallot in infants. BMC Med
Genomics. 5(20)2012.PubMed/NCBI View Article : Google Scholar
|
10
|
Sheng W, Qian Y, Wang H, Ma X, Zhang P,
Diao L, An Q, Chen L, Ma D and Huang G: DNA methylation status of
NKX2-5, GATA4 and HAND1in patients with tetralogy of fallot. BMC
Med Genomics. 6(46)2013.PubMed/NCBI View Article : Google Scholar
|
11
|
Qian Y, Xiao D, Guo X, Chen H, Hao L, Ma
X, Huang G, Ma D and Wang H: Hypomethylation and decreased
expression of BRG1 in the myocardium of patients with congenital
heart disease. Birth Defects Res. 109:1183–1195. 2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Scacheri PC, Crawford GE and Davis S:
Statistics for ChIP-chip and DNase hypersensitivity experiments on
NimbleGen arrays. Methods Enzymol. 411:270–282. 2006.PubMed/NCBI View Article : Google Scholar
|
13
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
14
|
Quinlan AR and Hall IM: BEDTools: A
flexible suite of utilities for comparing genomic features.
Bioinformatics. 26:841–842. 2010.PubMed/NCBI View Article : Google Scholar
|
15
|
Zhu LJ, Gazin C, Lawson ND, Pagès H, Lin
SM, Lapointe DS and Green MR: ChIPpeakAnno: A Bioconductor package
to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics.
11(237)2010.PubMed/NCBI View Article : Google Scholar
|
16
|
Ehrich M, Nelson MR, Stanssens P, Zabeau
M, Liloglou T, Xinarianos G, Cantor CR, Field JK and van den Boom
D: Quantitative high-throughput analysis of DNA methylation
patterns by base-specific cleavage and mass spectrometry. Proc Natl
Acad Sci USA. 102:15785–15790. 2005.PubMed/NCBI View Article : Google Scholar
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
18
|
Weisenberger DJ, Campan M, Long TI, Kim M,
Woods C, Fiala E, Ehrlich M and Laird PW: Analysis of repetitive
element DNA methylation by MethyLight. Nucleic Acids Res.
33:6823–6836. 2005.PubMed/NCBI View Article : Google Scholar
|
19
|
Hoff K, Lemme M, Kahlert AK, Runde K,
Audain E, Schuster D, Scheewe J, Attmann T, Pickardt T, Caliebe A,
et al: DNA methylation profiling allows for characterization of
atrial and ventricular cardiac tissues and hiPSC-CMs. Clin
Epigenetics. 11(89)2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Collins-Nakai R and McLaughlin P: How
congenital heart disease originates in fetal life. Cardiol Clin.
20:367–383, v-vi. 2002.PubMed/NCBI View Article : Google Scholar
|
21
|
Sheng W, Qian Y, Zhang P, Wu Y, Wang H, Ma
X, Chen L, Ma D and Huang G: Association of promoter methylation
statuses of congenital heart defect candidate genes with Tetralogy
of Fallot. J Transl Med. 12(31)2014.PubMed/NCBI View Article : Google Scholar
|
22
|
Sheng W, Chen L, Wang H, Ma X, Ma D and
Huang G: CpG island shore methylation of ZFPM2 is identified in
tetralogy of fallot samples. Pediatr Res. 80:151–158.
2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Zhang J, Ma X, Wang H, Ma D and Huang G:
Elevated methylation of the RXRA promoter region may be responsible
for its downregulated expression in the myocardium of patients with
TOF. Pediatr Res. 75:588–594. 2014.PubMed/NCBI View Article : Google Scholar
|
24
|
Grunert M, Dorn C, Cui H, Dunkel I, Schulz
K, Schoenhals S, Sun W, Berger F, Chen W and Sperling SR:
Comparative DNA methylation and gene expression analysis identifies
novel genes for structural congenital heart diseases. Cardiovasc
Res. 112:464–477. 2016.PubMed/NCBI View Article : Google Scholar
|
25
|
Serra-Juhé C, Cuscó I, Homs A, Flores R,
Torán N and Pérez-Jurado LA: DNA methylation abnormalities in
congenital heart disease. Epigenetics. 10:167–177. 2015.PubMed/NCBI View Article : Google Scholar
|
26
|
Obermann-Borst SA, Van Driel LM, Helbing
WA, de Jonge R, Wildhagen MF, Steegers EA and Steegers-Theunissen
RP: Congenital heart defects and biomarkers of methylation in
children: A case-control study. Eur J Clin Invest. 41:143–150.
2011.PubMed/NCBI View Article : Google Scholar
|
27
|
Chowdhury S, Cleves MA, Macleod SL, James
SJ, Zhao W and Hobbs CA: Maternal DNA hypomethylation and
congenital heart defects. Birth Defects Res A Clin Mol Teratol.
91:69–76. 2011.PubMed/NCBI View Article : Google Scholar
|
28
|
Jones PA: Functions of DNA methylation:
Islands, start sites, gene bodies and beyond. Nat Rev Genet.
13:484–492. 2012.PubMed/NCBI View Article : Google Scholar
|
29
|
Schultz MD, He Y, Whitaker JW, Hariharan
M, Mukamel EA, Leung D, Rajagopal N, Nery JR, Urich MA, Chen H, et
al: Human body epigenome maps reveal noncanonical DNA methylation
variation. Nature. 523:212–216. 2015.PubMed/NCBI View Article : Google Scholar
|
30
|
Neri F, Rapelli S, Krepelova A, Incarnato
D, Parlato C, Basile G, Maldotti M, Anselmi F and Oliviero S:
Intragenic DNA methylation prevents spurious transcription
initiation. Nature. 543:72–77. 2017.PubMed/NCBI View Article : Google Scholar
|
31
|
Schlesinger F, Smith AD, Gingeras TR,
Hannon GJ and Hodges E: De novo DNA demethylation and noncoding
transcription define active intergenic regulatory elements. Genome
Res. 23:1601–1614. 2013.PubMed/NCBI View Article : Google Scholar
|
32
|
Weinberg DN, Papillon-Cavanagh S, Chen H,
Yue Y, Chen X, Rajagopalan KN, Horth C, McGuire JT, Xu X, Nikbakht
H, et al: The histone mark H3K36me2 recruits DNMT3A and shapes the
intergenic DNA methylation landscape. Nature. 573:281–286.
2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Chen B, Bronson RT, Klaman LD, Hampton TG,
Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP and Neel BG:
Mice mutant for Egfr and Shp2 have defective cardiac semilunar
valvulogenesis. Nat Genet. 24:296–299. 2000.PubMed/NCBI View
Article : Google Scholar
|
34
|
Taparia S, Gelineau-van Waes J, Rosenquist
TH and Finnell RH: Importance of folate-homocysteine homeostasis
during early embryonic development. Clin Chem Lab Med.
45:1717–1727. 2007.PubMed/NCBI View Article : Google Scholar
|
35
|
MacGrogan D, D'Amato G, Travisano S,
Martinez-Poveda B, Luxán G, Del Monte-Nieto G, Papoutsi T, Sbroggio
M, Bou V, Gomez-Del Arco P, et al: Sequential ligand-dependent
notch signaling activation regulates valve primordium formation and
morphogenesis. Circ Res. 118:1480–1497. 2016.PubMed/NCBI View Article : Google Scholar
|
36
|
McBride KL, Riley MF, Zender GA,
Fitzgerald-Butt SM, Towbin JA, Belmont JW and Cole SE: NOTCH1
mutations in individuals with left ventricular outflow tract
malformations reduce ligand-induced signaling. Hum Mol Genet.
17:2886–2893. 2008.PubMed/NCBI View Article : Google Scholar
|
37
|
Mortensen SA, Skov LL, Kjaer-Sorensen K,
Hansen AG, Hansen S, Dagnæs-Hansen F, Jensenius JC, Oxvig C, Thiel
S and Degn SE: Endogenous natural complement inhibitor regulates
cardiac development. J Immunol. 198:3118–3126. 2017.PubMed/NCBI View Article : Google Scholar
|
38
|
Cui Y, Zheng Y, Liu X, Yan L, Fan X, Yong
J, Hu Y, Dong J, Li Q, Wu X, et al: Single-cell transcriptome
analysis maps the developmental track of the human heart. Cell Rep.
26:1934–1950.e5. 2019.PubMed/NCBI View Article : Google Scholar
|